Abstract
Background Vitamin D is implicated in many processes in the central nervous system (CNS), such as neurogenesis, neurotransmitter synthesis, synaptogenesis and protection against oxidative stress, thereby exerting a neuroprotective effect. Objective In the present review, we aimed to evaluate the potential benefit(s) of vitamin D supplementation for CNS aging in different clinical contexts. Methods We performed a literature search, looking for clinical trials and randomized clinical trials evaluating the effect of vitamin D supplementation on different endpoints related to cognitive outcomes. Results Firstly, we identified 16 papers dealing with the impact of vitamin D supplementation on cognitive function in healthy subjects; the current literature suggests a real role for vitamin D supplementation in the prevention of cognitive decay in this clinical setting. Conversely, two papers suggest that vitamin D supplementation may be beneficial in patients with mild cognitive impairment (MCI). Finally, current data on vitamin D in Alzheimer's disease are contradictory. Conclusion Vitamin D supplementation may improve the cognitive outcomes of patients with MCI, whereas there is no evidence that it may prevent dementia or modulate the course of Alzheimer's disease.
Lingua originale | Inglese |
---|---|
pagine (da-a) | 628-637 |
Numero di pagine | 10 |
Rivista | CNS & NEUROLOGICAL DISORDERS. DRUG TARGETS |
Volume | 23 |
Numero di pubblicazione | 5 |
DOI | |
Stato di pubblicazione | Pubblicato - 2024 |
Keywords
- Alzheimer’s disease
- Vitamin D
- cholecalciferol
- cognitive decline
- dementia
- mild cognitive impairment